Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBANDRONATE vs IBREXAFUNGERP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBANDRONATE vs IBREXAFUNGERP: Safety Overview

Metric IBANDRONATE IBREXAFUNGERP
Total FAERS Reports 10,178 129
Deaths Reported 236 6
Death Rate 2.3% 4.7%
Hospitalizations 1,420 9
Average Patient Age 69.0 yrs 44.4 yrs
% Female Patients 95.4% 85.2%
FDA Approval Date Apr 30, 2012 Jun 1, 2021
Manufacturer Eugia US LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription